Faculty Information - Masayuki Inubushi

（Last updated : 2024-05-24 18:10:25）

Masayuki Inubushi
Department Kawasaki Medical School Faculty of Medicine, Kawasaki Medical School,

Position

■ Journal

1.	2024	A Luciferase Reporter Assay to Detect Cellular Hypoxia In Vitro.
2.	2024	Radionuclide Reporter Imaging to Visualize Tumor Hypoxia Ex Vivo and In Vivo.
3.	2023/07/03	Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer.
4.	2020/12	Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen.
5.	2020/08	Imaging of Hypoxic Tumor: Correlation between Di usion-weighted MR Imaging and 18F- uoroazomycin Arabinoside Positron Emission Tomography in Head and Neck Carcinoma
6.	2019/12	From the respective expert viewpoints of the ANM specialty editors
7.	2019/11	Effect of drugs containing glucose on FDG-PET image quality
8.	2018/11	European research trends in nuclear medicine
9.	2017/09	64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.
10.	2017/07	Topics of nuclear medicine research in Europe.
11.	2017/04	18F-FDG PET/CT Imaging of Epididymal Smooth Muscle Mass Mimicking Recurrent Lymphoma.
12.	2016/12	Introduction of nuclear medicine research in Japan.
13.	2016/08	Functional evaluation of rat hearts transplanted after preservation in a high-pressure gaseous mixture of carbon monoxide and oxygen.
14.	2016/07	Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan.
15.	2016/04	Prognostic value of PET/CT with 18F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
16.	2016/03	Atypical femoral fracture in a patient with metastatic breast cancer during Denosumab therapy.
17.	2016/01	In Vivo Simultaneous Imaging of Vascular Pool and Hypoxia with a HT-29 Tumor Model: the Application of Dual-Isotope SPECT/PET/CT
18.	2015/11	Prognostic value of 18 F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small cell lung cancer.
19.	2015/09	Polymeric Micelle Platform for Multimodal Tomographic Imaging to Detect Scirrhous Gastric Cancer
20.	2015/06	Performance characteristics of a novel clustered multi-pinhole technology for simultaneous high-resolution SPECT/PET.
21.	2015/01	Performance characteristics of a novel clustered multi-pinhole technology for simultaneous high-resolution SPECT/PET.
22.	2014/12	Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions.
23.	2014/04	FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
24.	2014	Oncology PET imaging
25.	2013/07	Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
26.	2013	Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
27.	2012/09	Single-photon emission computed tomography of spontaneous liver metastasis from orthotopically implanted human colon cancer cell line stably expressing human sodium/iodide symporter reporter gene.
28.	2012	Long-term effects of hepatocyte growth factor gene therapy in rat myocardial infarct model.
29.	2012	Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma.
30.	2011	Development of positron emission tomography probe of 64Cu-labeled anti-C-kit 12A8 Fab to measure protooncogene C-kit expression.
31.	2011	Establishment of stable human glioma cell lines expressing radionuclide reporter gene responsive to hypoxia.
32.	2011	PET/CT with 3'-deoxy-3'-[18F]fluorothymidine for lung cancer patients receiving carbon-ion radiotherapy.
33.	2011	Uptake Decrease of Proliferative PET Tracer (18)FLT in Bone Marrow after Carbon Ion Therapy in Lung Cancer.
34.	2010	High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodexyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up.
35.	2009	Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.
36.	2009	Therapeutic effects of acupuncture in patients with rheumatoid arthritis: a prospective study using (18)F-FDG-PET.
37.	2008	Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
38.	2008	Incidence and characteristics of uterine leiomyomas with FDG uptake.
39.	2007	Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.
40.	2007	Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
41.	2007	Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension.
42.	2007	Lymphadenopathy due to amyloidosis secondary to Sjogren syndrome and systemic lupus erythematosus detected by F-18 FDG PET.
43.	2007	Physiological FDG uptake in the ovaries after hysterectomy.
44.	2007	Radionuclide reporter gene imaging for cardiac gene therapy.
45.	2006	Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease.
46.	2006	PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.
47.	2006	Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers.
48.	2005	Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers.
49.	2005	Positron emission tomography reporter gene imaging in the myocardium: for monitoring of angiogenic gene therapy in ischemic heart disease.
50.	2004	Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion.
51.	2004	PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography.
52.	2003	PET imaging in small animals.
53.	2003	Positron-emission tomography reporter gene expression imaging in rat myocardium.
54.	2002	Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph.
55.	2002	Optical imaging of cardiac reporter gene expression in living rats.
56.	2002	Positron emission tomography imaging of cardiac reporter gene expression in living rats.
57.	2002	Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension.
58.	2001	Assessment of the effect of revascularization early after CABG using ECG-gated perfusion single-photon emission tomography.
59.	2001	Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
60.	2001	Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography.
61.	2000	Dual SPECT imaging of Loffler's endomyocarditis in the acute phase.
62.	2000	Iodinated free fatty acid and 201T1 uptake in chronically hypoperfused myocardium: histologic correlation study.
63.	1999	An ultrashort 1-day protocol of Tc-99m tetrofosmin.
64.	1999	Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging.
65.	1999	Improvement of regional myocardial and coronary blood flow reserve in a patient treated with enhanced external counterpulsation: evaluation by nitrogen-13 ammonia PET.
66.	1999	Simultaneous assessment of myocardial free fatty acid utilization and left ventricular function using 123I-BMIPP-gated SPECT.
67.	1999	Use of technetium-99m sestamibi ECG-gated single-photon emission tomography for the evaluation of left ventricular function following coronary artery bypass graft: comparison with three-dimensional magnetic resonance imaging.
68.	1998	Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus.
69.	1998	First-pass radionuclide angiography using iodine-123 myocardial tracers and a multicrystal gamma camera.
70.	1998	Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
71.	1997	Recent advances in nuclear cardiology in the study of coronary artery disease.
Display 5 items
Display all(71)

■ Presentation

1.	2022/09/07	“Ant-farm”-like Appearance; Characteristic F-18 Fluorodeoxyglucose Positron-Emission Tomographic Findings of Restricted （Poster notice，Keynote）
2.	2018/10/15	Development of Human Sodium/lodide Symporter(hNIS) Transgenic Mouse as Resource of Stem Cells for in vivo Cell Tracking （Speech，General）
3.	2018/04/23	Development of Human Sodium/Iodide Symporter (hNIS) Transgenic Mouse as Resource of Stem Cells for in vivo Cell Tracking （Poster notice，General）
4.	2017/04/24	Hypoxia imaging of head and neck carcinoma : Correlation between DWI parameters and FAZA-PET activity （Poster notice，General）
5.	2016/06/11	In Vivo Simultaneous Imaging of Vascular Pool and Hypoxia with a HT-29 Tumor Model: the Application of Dual-Isotope SPECT/PET/CT （Speech，General）
6.	2015/12/18	Evaluation of simultaneous dual-isotope SPECT/PET/CT imaging with 99mTc and 64Cu by phantom study and its in vivo application （General）
7.	2015/10/10	Clinical Value of FAZA-PET/CT in Head and Neck Cancer Patients. （General）
8.	2015/09/02	Clinical value of FAZA-PET/CT in advanced lung cancer patients: comparison with FDG-PET/CT. （General）
9.	2015/06/06	Performance characteristics of a novel clustered multi-pinhole technology for simultaneous high-resolution SPECT/PET. （Speech，General）
10.	2015/05/25	Seamless quantitative assessments from whole body to cellular level for high dose radiation-induced mouse intestinal injury/rescue.
11.	2014/11/30	A diagnostic imaging education system for lung CT images based on image-retrieval technology for medical books and DICOM images （General）
12.	2014/09/17	Rat cardiac function estimated with new wireless gating method for cone-beam CT. （General）
13.	2014/08/27	Cross-validation of Left Ventricular Function Obtained from Intrinsically Gated Computed Tomography and Retrospectively Self-gated (IntraGate) Magnetic Resonance Imaging in Rats. （General）
14.	2014/06/07	Clinical evaluation of 18F-FAZA and 18F-FDG PET/CT for advanced lung cancer patients （General）
15.	2014/06/07	Simultaneous PET/SPECT imaging to compare tumor uptake level of 18F-FMISO with 64Cu-ATSM on the basis of the genetic activation level responding to tumor hypoxia. （General）
16.	2013/12/01	Comparison of Intratumoral 18FDG and 18FAZA Distribution in Non-small Cell Lung Cancer Using Deformable Image Registration. （Speech，General）
17.	2013/12/01	Comparison of Intratumoral 18FDG and 18FAZA Distribution in Non-small Cell Lung Cancer Using Deformable Image Registration.
18.	2013/12/01	FDG Uptake Heterogeneity Evaluated by Fractal Analysis Improves the Differential Diagnosis of Pulmonary Nodules. （Speech，General）
19.	2013/11/16	Noninvasive spatial and temporal tracking of multilayered cell sheet on infarcted heart using reporter gene imaging. （Speech，General）
20.	2013/06/12	Comparison of intratumoral distribution of 18F-FMISO and 64Cu-ATSM with regions genetically responding to hypoxia by quantitative cluster analyses （General）
21.	2013/06/08	The imaging of tumor hypoxia with 18F-FMISO and 18F-FAZA in comparison to the imaging of hypoxic response with radioiodine using sodium/iodine symporter (NIS) reporter gene in human xenograft tumors. （Speech，General）
22.	2013/04/11	Comparison of intratumoral distribution of 18FDG and 18FAZA using deformable image registration procedure in non-small cell lung cancer patients. （Speech，General）
23.	2012/10/27	Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma （Poster notice，General）
24.	2012/09/05	Tracking of transplanted stem cells in myocardial infarction model rat: validation of simultaneous dual-isotope SPECT imaging with Tc-99m and Tl-201 （Poster notice，General）
25.	2012/06/09	Clinical differentiation between malignant and benign pulmonary nodules using heterogeneity of 18F-FDG uptake distribution （Poster notice，General）
26.	2012/06/09	Molecular genetic imaging of hypoxia response using sodium/iodide symporter (NIS) reporter gene （Poster notice，General）
27.	2011/11/27	Quantitative response to therapy in non-Hodgkin's lymphoma using partial volume correction by FDG PET/CT. （Speech，General）
28.	2011/10/15	Initial report on [18F]FAZA-PET Clinical Study in Lung Cancer. （Speech，General）
29.	2011/09/29	Radiation shielding for beta and bremsstrahlung radiation from Sr-89 and Y-90. （Speech，General）
30.	2011/09/07	Mouse spontaneous liver metastasis model from orthotopic human colon cancer xenograft stably expressing human sodium-iodide symporter reporter gene. （Speech，General）
31.	2011/06/04	Investigation of factors affecting the recovery coefficients in FDG PET/CT: Effects of target size, background activity and respiratory motion. （Speech，General）
32.	2011/06/04	Validation of the optimal index for monitoring early tumor changes between two scans in FDG PET/CT. （Speech，General）
33.	2011/06/04	Value of rigid control of respiratory in PET/CT imaging in patients with lung cancer: meta-analysis. （Speech，General）
34.	2010/09/18	[18F]FDG-PET studies of heterotopic heart transplantation in rats. （Speech，General）
35.	2010/09/18	Hepatocyte growth factor angiogenic gene therapy in rat myocardial infarct model: multimodal assessment with cine MRI, SPECT/CT, and two-photon excitation fluorescent microscopy. （Speech，General）
36.	2010/09/08	Multimodal assessment of hepatocyte growth factor angiogenic gene therapy in rat myocardial infarct model. （Poster notice，General）
37.	2010/03/05	Sodium iodide symporter gene for cell tracking. （Speech，General）
38.	2009/11/29	Ideata-base: an intelligent database management system of a body of knowledge. （Speech，General）
39.	2009/10/10	A proliferative PET tracer, F-18 FLT, uptake decreases in bone marrow after carbon ion radiation therapy. （Speech，General）
40.	2009/10/10	FLT-PET/CT for Lung Cancer Patients Receiving Carbon-Ion Radiation Therapy: Prognostic Significance. （Speech，General）
41.	2009/10/10	Practical performance evaluation of a commercial small animal SPECT system with a single-pinhole or 5-hole collimator. （Speech，General）
42.	2009/10/10	Radionuclide reporter gene imaging of mouse xenograft model of human colon cancer cell lines stably expressing human sodium-iodide symporter (hNIS). （Speech，General）
43.	2009/09/23	C-kit-specific PET/SPECT imaging in a mouse model of small cell lung cancer. （Speech，General）
44.	2009/06/22	Cardiology -Ischemia. RTC on Advanced Clinical Applications of PET. （Speech，Special/Invited Lecture）
45.	2008/10/11	Assessment of hypoxia-responsive elements for hypoxia-targeting imaging and therapy. （Speech，General）
46.	2008/10/11	FLT-PET for the evaluation of lung cancer patients treated with carbon-ion radiation therapy: initial results. （Speech，General）
47.	2008/09/10	Na/I symporter (NIS) reporter gene imaging system for evaluating angiogenic gene therapy using hepatocyte growth factor (HGF) （Speech，General）
48.	2008/03/30	Optical and radionuclide reporter gene imaging for cardiovascular regeneration therapy, in Topic 2: Role of Molecular Imaging for Cardiovascular Regeneration Treatments （Speech，Special/Invited Lecture）
49.	2007/09/09	Molecular Imaging in Heart Failure. （Speech，Special/Invited Lecture）
50.	2007/06/05	Relationship of 18F-FDG/99mTc-annexin A5 uptake and lipid contents in atherosclerotic lesions of ApoE-/-mice （Speech，General）
51.	2007/06/04	18F-FLT but not 18F-FDG can early and dose-dependently detect antiproliferative responses of human tumor xenograft to epidermal growth factor receptor targeting with a tyrosine kinase inhibitor, gefitinib （Speech，General）
52.	2007/04/28	Molecular Imaging for Cardiac Neuronal Transmission(Invited Lecture) （Speech，Special/Invited Lecture）
53.	2007/04/28	Molecular Imaging Seminar-Lesding Edge in Cardiovascular Molecular Imaging (Invited Lecture) （Speech，Special/Invited Lecture）
54.	2006/10/22	Usefulness of [C-11]methionine in differentiating tumor from granuloma : comparison with [F-18]FDG. （Speech，General）
55.	2006/07/14	Monitoring early response to molecular-targeting therapy (Iressa) in human tumor xenograft using 18F-FLT. （Speech，General）
56.	2006/06/03	Automated algorithm for quantification of left ventricular ejection fraction with 15O-water and 15O-CO PET. （Speech，General）
57.	2006/06/03	Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/-mice （Speech，General）
58.	2006/06/03	Determinants of coronary endothelial dysfunction in hypertensive patients. Cardiovascular Young Investigator Award Symposium （Speech，General）
59.	2006/06/03	Effect of angiotensin type 1 receptor blockade on coronary vasomotion assessed by 15O-water PET in patients with hypertension. （Speech，General）
60.	2006/06/03	Effects of long-term cholesterol feeding on aortic accumulation of 18F-FDG and 99mTc-annexin A5 in ApoE-/-and normal mice （Speech，General）
61.	2006/06/03	Improvement of Myocardial Perfusion and Ejection Fraction after PCI in Patients with Chronic total coronary occlusion without Myocardial Infarction （Poster notice，General）
62.	2006/06/03	Predictors of LVEF improvement after 1-year beta-blocker therapy in patients with heart failure using 11C-CGP-12177 and 123I-MIBG. （Speech，General）
63.	2006/06/02	Cancer screening trial to evaluate the efficacy of FDG-PET in healthy subjects -2-year results of the Hamamatsu Medical Imaging Center study. （Speech，General）
64.	2006/04/04	Beta-adrenergic receptor imaging (Invited lecture) （Speech，Special/Invited Lecture）
65.	2006/03/24	Decreased Myocardial Beta-adrenergic Receptor Density in Relation to increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy:PETbStudy with 11C-CGP-12177 (Featured Research Session) （Speech，Special/Invited Lecture）
66.	2006/03/24	Quantitative Assessment of Coronary Endothelial Function Using PET and Effects of Angiotensin Receptor Blockade Therapy in Patients with Hypertension. （Speech，Special/Invited Lecture）
67.	2006/03/24	Reversible Coronary Endothelial Dysfunction by Smoking Cessation in Young Smokers-Assessment with O-15 Labeled Water and PET- （Speech，Special/Invited Lecture）
68.	2005/11/11	Myocardial Beta-Adrenergic Receptor Density Measurement in Patients with Left Ventricular Dysfunction. (Featured Research Session) （Speech，Special/Invited Lecture）
69.	2005/05/13	Cancer screening trial using whole-body 18F-FDG-PET scanin healthy subjects - Hamamatsu Medical Imaging Center study. （Speech，General）
70.	2005/04/04	Gene expression imaging in myocardium: for monitoring angiogenic gene therapy for ischemic heart disease. (Invited lcture) （Speech，Special/Invited Lecture）
71.	2004/11/28	A Lifelike Scalable Image Workspace for Filmless Radiology. （Speech，General）
72.	2004/11/28	Intelligent Interactive Educational Support System for Diagnostic Imaging Based on Knowledge Iterative Organizing System (KIOS). （Speech，General）
73.	2004/09/04	Duodenal FDG uptake in healthy volunteers. （Speech，General）
74.	2004/06/19	Brain FDG PET imaging in a population-based corhot of asymptomatic subjects: initial findings. （Speech，General）
75.	2004/06/19	FDG uptake in the normal ovary and uterus changes according to the menstrual cycle. （Speech，General）
76.	2003/11/22	PET reporter gene expression imaging in myocardium: for monitoring of angiogenic gene therapy for ischemic heart disease. (Designated lecture) （Speech，Special/Invited Lecture）
77.	2003/06/25	Abnormal myocardial blood flow (MBF) response to cold pressor testing (CPT) in post-menoposal women with and without coronary risk factors-relation to MBF at rest. （Speech，General）
78.	2003/06/21	Abnormal longitudinal, base-to-apex perfusion gradient in response to cold-pressor-test in patients with coronary risk factors. （Speech，General）
79.	2003/06/21	Elevated resting myocardial blood flow (MBF) in pre-diabetic subjects with insulin resistance is associated with a decreased response to cold pressor test (CPT) and adenosine as measured by PET. （Speech，General）
80.	2003/06/21	Inter- and intra-operator variability in myocardial blood flow (MBF) measurement using 13N-ammonia. （Speech，General）
81.	2003/06/21	Noninvasive measurement of experimental myocardial infarctions in mice using microPET polar maps. （Speech，General）
82.	2003/06/21	PET-measured responses in myocardial blood flow to cold pressor testing correlate with indices of coronary vasomotion on quantitative angiography. （Speech，General）
83.	2003/06/21	Severe coronary artery calcification by electron beam computed tomography (EBCT) in asymptomatic subjects is not correlated with coronary circulatory dysfunction as measured by PET. （Speech，General）
84.	2002/06/15	Imaging adenoviral mediated HSV1-sr39tk reporter gene expression in rat myocardium with microPET and FHBG. （Speech，General）
85.	2002/06/15	PET and optical imaging of cardiac reporter gene expression in living rats. （Speech，General）
86.	2002/06/15	Quantitative measurement of myocardial blood flow with 13N-ammonia and microPET in mice. （Speech，General）
87.	2002/06/05	Imaging adenoviral mediated HSV1-sr39tk reporter gene expression in rat myocardium with immunohistochemistry, autoradiography and microPET imaging. （Speech，General）
88.	2002/06/05	Monitoring of cardiac gene expression in living rats with optical imaging. （Speech，General）
89.	2002/03/17	Optical imaging of adenoviral mediated cardiac gene expression in living rats. （Speech，General）
90.	2001/10/24	Effects of heart rate on left ventricular function and perfusion demonstrated noninvasively in anesthetized mice. （Speech，General）
91.	2000/11/12	Different responses in heart and lung of 123I-MIBG metabolism to nasal continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. （Speech，General）
92.	2000/06/03	Heterogeneity of myocardial 123I-BMIPP distributions in patients with aortic valve disease: effect of aortic valve replacement. （Speech，General）
93.	2000/06/03	Identification of embolic fate through patent foramen ovale demonstrated by 99mTc-MAA brain SPECT after valsalva venography. （Speech，General）
94.	2000/06/03	Myocardial viability assessment using 18F-FDG gated PET. （Speech，General）
95.	1999/11/07	Importance of oxidative metabolism in definition of heart failure state and prediction of cardiac events. （Speech，General）
96.	1999/11/07	The new therapeutic approach with the Enhanced External Counterpulsation in patients with chronic stable angina: Evaluation of myocardial flow and flow reserve by N-13-Ammonia PET. （Speech，General）
97.	1999/06/06	Exercise induced abnormalities of cardiac function in patients with type-II diabetes. （Speech，General）
98.	1999/06/06	Steal phenomenon in pediatric hypertrophic cardiomyopathy after dipyridamole infusion. （Speech，General）
99.	1999/04/18	Assessment of left ventricular volume by reinjection Tl-201 and rest Tc-99m MIBI ECG-gated SPECT and magnetic resonance imaging (MRI). （Speech，General）
100.	1999/04/18	Gender difference of the ejection fraction in hyperlipidemic patients. （Speech，General）
101.	1999/04/18	Simultaneous assessment of myocardial fatty acid utilization and LV function using I-123 BMIPP gated SPECT (GSPECT). （Speech，General）
102.	1999/04/18	Transient ischemic dilatation ratio before and after CABG in patients with severe coronary artery disease assessed with stress/reinjection Tl-201 ECG-gated SPECT. （Speech，General）
103.	1998/06/07	Evaluation of regional and global ventricular function by gated Tc-99m sestamibi SPECT after CABG: comparison with cine MRI. （Speech，General）
104.	1998/06/07	Noninvasive measurement of the input function with Time-of-Flight positron measuring system: comparison with arterial blood sampling. （Speech，General）
105.	1998/06/07	Regional abnormality in I-123 MIBG myocardial SPECT is a strong predictive factor of cardiovascular events in diabetes. （Speech，General）
106.	1998/06/07	Relative myocardial metabolic rate of glucose reflects myocardial histological change better than absolute metabolic rate of glucose. （Speech，General）
107.	1997/11/30	Feasibility of first-pass ventriculography with I-123 myocardial tracers and a multicrystal camera. （Speech，General）
108.	1997/11/09	C-11 acetate PET with low-dose dobutamine infusion can deliniate viable myocardium: comparison with FDG PET. （Speech，General）
109.	1997/06/01	A Time-of-Flight multi-probe system for quantifying positron-emitting tracer in a target region. （Speech，General）
110.	1997/06/01	Decreased BMIPP uptake precedes the impairment of oxygen and glucose metabolism in patients with hypertrophic cardiomyopathy. （Speech，General）
111.	1997/06/01	Histological analysis of thallium and radioiodinated branched fatty acid uptake in ischemic myocardium in man. （Speech，General）
112.	1997/06/01	Hyper-reaction against dobutamine stress in severely denervated diabetic hearts. （Speech，General）
113.	1997/06/01	Myocardial perfusion and metabolism reflect myocardial histological change in ischemic myocardium in man. （Speech，General）
114.	1997/06/01	Reduced coronary flow reserve of hypertensive patients with normal perfusion imaging. （Speech，General）
115.	1997/04/06	Myocardial fibrosis and uptake of radioiodinated branched fatty acid: histopathological correlation. （Speech，General）
116.	1997/04/06	Regional heterogeneity of oxygen metabolism in normal human hearts. （Speech，General）
117.	1996/09/30	Heterogeneous washout of N-13 ammonia with homogeneous myocardial perfusion assessed with dynamic PET. （Speech，General）
118.	1996/09/30	I-123 BMIPP/Tl mismatch predicts wall motion recovery after CABG: assessment with quantitative analysis. （Speech，General）
119.	1996/09/30	Oxydative metabolism in diabetic hearts; assessed by C-11 acetate PET. （Speech，General）
Display 5 items
Display all(119)